# GPT 5.2 Review - Reviewer 2/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T14:27:21.562190
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_0d4ceef54a1a441200697b5f87d7c081a39b6f1a70c631f60b
**Tokens:** 18082 in / 5438 out
**Response SHA256:** 9b48e52a473c37c9

---

## Referee Report (Top General-Interest Economics Journal Standard)

### Summary
This manuscript is primarily a **data-infrastructure and visualization** paper. It builds an integrated crash-level dataset for Western US states by combining **FARS fatal crashes** with **OpenStreetMap (OSM) road attributes** and **state marijuana policy timing**, and it presents descriptive patterns (notably cross-state differences in THC findings in 2018–2019 and visual discontinuities near borders). The construction effort is potentially valuable; however, **for a top general-interest journal or AEJ:EP, the paper is not currently close to publishable** because it does not deliver a credible causal design with formal estimation and statistical inference, and it does not meet core econometric standards for RDD/DiD designs it repeatedly motivates.

---

# 1. FORMAT CHECK (fixable, but must be flagged)

### Length
- The PDF pagination shown runs to **~29 pages including appendix** (pages displayed up to p.29 in Appendix B).
- The **main text appears to end around p.24–25**, with references beginning on p.25 and appendix thereafter. **Excluding references/appendix, the paper likely falls below (or at best barely meets) a 25-page minimum** expected in many top journals. If the main text is <25 pages, it fails the stated target.

### References coverage
- The bibliography (p.25–26) is **far too thin** for the topic and for the econometric designs invoked. It cites only a small handful of papers (e.g., Anderson et al. 2013; Pacula et al. 2015; Keele & Titiunik 2015; Callaway & Sant’Anna 2021; Sun & Abraham 2021; Boeing 2017; NHTSA report).
- Missing are foundational RDD references, spatial inference references, and a substantial body of marijuana-traffic safety evidence.

### Prose vs bullets
- The paper is mostly in paragraph form in the Introduction (Section 1) and narrative sections, which is good.
- Bullets are heavily used in Section 2 and the Appendix variable definitions (pp.4–6; p.27), which is acceptable for data documentation. **No major “Introduction written as bullets” issue.**

### Section depth (3+ substantive paragraphs each)
- Some sections are thin and read like extended figure captions rather than full sections:
  - **Section 4 (“Showcase: Zooming In”)** is largely figure-by-figure description (pp.12–16) and does not reach the depth expected for a top-journal results section.
  - **Section 6 (“Policy Border Patterns”)** is short and largely descriptive (pp.17–18), and it explicitly states limitations that prevent real designs.
  - The Discussion/Limitations section (Section 9, pp.23–24) is present, but it mostly reiterates constraints rather than analyzing threats and empirical remedies.

### Figures
- Several figures are publication-quality (e.g., Figures 1–3 with axes).
- Many **maps lack axes/ticks** (acceptable for maps) but must have **clear scale bars, legends, and definitional notes** (some do; e.g., Fig.5–8 show legends and sometimes scale bars).
- Some “RDD-style” plots appear in the appendix (Fig.15, p.29) but **still do not implement canonical RDD diagnostics** (see below).

### Tables
- Table 1 and Table 2 contain real numbers and are not placeholders (pp.6–8). This is fine.
- Table 2’s Panel labeling is inconsistent (Panel D appears before Panel C on p.7), which signals rushed editing.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL — currently fails)

The paper **cannot pass** a top-journal review because it does **not perform formal statistical inference** and does **not estimate** the causal objects it repeatedly motivates.

### (a) Standard Errors
- **No regression tables. No coefficients with SEs.**
- Numerous claims are made using differences in means and visual discontinuities (e.g., p.1 Abstract; p.8 Table 2 Panel C; p.9 Figure 2), but **there are no SEs, CIs, randomization/permutation inference, or clustered variance estimates**.

**Result: FAIL.** Under the referee criteria you provided, this alone makes the paper unpublishable.

### (b) Significance testing
- No hypothesis tests are conducted anywhere in the manuscript.

**FAIL.**

### (c) Confidence intervals
- No 95% confidence intervals for any key estimand (THC difference across legal/illegal, border discontinuity, trends).

**FAIL.**

### (d) Sample sizes for regressions
- There are no regressions; thus no regression N reporting. Some figures report N (e.g., Fig.5 “N=1353 crashes with any drug record”; Fig.6 N=599), which is good practice, but not a substitute.

**FAIL for regression inference standards.**

### (e) DiD with staggered adoption
- The paper explicitly discusses DiD (Section 8.2, pp.21–22) and correctly cites modern estimators (Callaway & Sant’Anna; Sun & Abraham). However, it **does not implement any DiD design**, and the dataset as described omits 2006–2015, which makes staggered timing analysis largely infeasible.
- It also admits “Timing caveat” in Table 2 notes (p.8): CA and NV are grouped as “Legal” even in 2016 pre-legalization for those states. That is fine for descriptive grouping but would be **unacceptable** for treatment coding in causal DiD.

**As a causal paper: FAIL (not implemented).**

### (f) RDD (spatial)
- The paper motivates spatial RDD (Section 8.1, p.20) and shows border maps and an “RDD-style plot” (Fig.15, p.29), but it **does not**:
  - choose and justify a bandwidth,
  - show bandwidth sensitivity,
  - implement robust bias-corrected local polynomial estimation (Calonico-Cattaneo-Titiunik),
  - run manipulation/sorting checks (McCrary-style density test adapted to geographic running variables),
  - show covariate continuity balance at the border,
  - address spatial correlation / correct inference.

**FAIL.**

### Bottom line on methodology
Even if the paper positions itself as “methodological and descriptive rather than causal” (p.2), a top general-interest journal will still require (i) **formal estimation** of central claims and (ii) **inference**. Currently, the manuscript is closer to a **technical report/data note** than an economics article meeting AER/QJE/JPE/ReStud/Ecta or AEJ:EP standards.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- The paper does **not actually execute** an identification strategy. It provides visual/descriptive evidence and repeatedly states that its contribution is infrastructure and motivation (e.g., Section 1, p.2; Section 6.2, p.18; Section 8, p.19–23).
- The border discontinuity claims (“visible discontinuities” Abstract p.1; Section 4.1 p.12) are **not identified causal effects** because:
  - THC “positivity” is not measured on a consistent tested denominator (pp.3–4; p.20–22),
  - reporting/testing selection differs by state (Section 7.2 p.20–21),
  - crashes are a selected subset of driving behavior, and
  - border regions differ in urbanization, enforcement, commuting patterns.

### Assumptions discussed?
- Continuity/validity assumptions for spatial RDD are mentioned only at a high level (Section 8.1, p.20) without operational checks.
- Parallel trends are acknowledged as untestable given missing years (Section 8.2, p.22), effectively conceding DiD limitations.

### Placebos/robustness
- No placebo borders, no fake-policy dates, no pre-period border checks, no donut RDD, no alternate running variables (e.g., travel-time-to-border), no alternative outcome definitions.

### Do conclusions follow?
- The paper mostly avoids overclaiming causality, which is good. But it still emphasizes patterns that readers will interpret causally (“motivating spatial RDD designs”; “sharp policy discontinuities”) while not delivering the associated econometrics.

### Limitations discussed?
- Section 7 and Section 9 are candid and helpful (pp.19–24), especially about drug reporting and THC impairment interpretation. This is a strength. But for a top journal, limitations must be paired with **empirical strategies that quantify sensitivity** (selection bounds, measurement error models, etc.).

---

# 4. LITERATURE (missing references + BibTeX)

## Major omissions (methods)
You cite Keele & Titiunik (2015), but **foundational RDD and modern RDD practice is missing**, and **spatial correlation inference** is not addressed.

You also cite Callaway & Sant’Anna and Sun & Abraham, but key DiD references and diagnostics are missing.

### Must-cite: RDD foundations and practice
```bibtex
@article{ImbensLemieux2008,
  author = {Imbens, Guido W. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  number = {2},
  pages = {615--635}
}

@article{LeeLemieux2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  number = {2},
  pages = {281--355}
}

@article{CalonicoCattaneoTitiunik2014,
  author = {Calonico, Sebastian and Cattaneo, Matias D. and Titiunik, Rocio},
  title = {Robust Nonparametric Confidence Intervals for Regression-Discontinuity Designs},
  journal = {Econometrica},
  year = {2014},
  volume = {82},
  number = {6},
  pages = {2295--2326}
}

@article{McCrary2008,
  author = {McCrary, Justin},
  title = {Manipulation of the Running Variable in the Regression Discontinuity Design: A Density Test},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  number = {2},
  pages = {698--714}
}
```

### Must-cite: DiD with staggered adoption + diagnostics
```bibtex
@article{GoodmanBacon2021,
  author = {Goodman-Bacon, Andrew},
  title = {Difference-in-Differences with Variation in Treatment Timing},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  number = {2},
  pages = {254--277}
}

@article{BorusyakJaravelSpiess2021,
  author = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title = {Revisiting Event Study Designs: Robust and Efficient Estimation},
  journal = {arXiv preprint arXiv:2108.12419},
  year = {2021}
}

@article{RothSantAnnaBilinskiPoe2023,
  author = {Roth, Jonathan and Sant'Anna, Pedro H. C. and Bilinski, Alyssa and Poe, John},
  title = {What's Trending in Difference-in-Differences? A Synthesis of the Recent Econometrics Literature},
  journal = {Journal of Econometrics},
  year = {2023},
  volume = {235},
  number = {2},
  pages = {2218--2244}
}
```

### Must-cite: spatial correlation / spatial HAC / border inference concerns
For border RDD and geocoded outcomes, inference must account for spatial dependence.
```bibtex
@article{Conley1999,
  author = {Conley, Timothy G.},
  title = {GMM Estimation with Cross Sectional Dependence},
  journal = {Journal of Econometrics},
  year = {1999},
  volume = {92},
  number = {1},
  pages = {1--45}
}
```

## Major omissions (substance use + traffic safety + cannabis policy)
You cite Anderson et al. (2013) and Hansen et al. (2015) (the latter is teen use, not traffic). The empirical marijuana-traffic literature is much larger. At minimum, you need systematic engagement with:
- recreational legalization and traffic fatalities/injuries,
- drug testing and FARS measurement issues,
- THC impairment interpretation.

Examples to add (illustrative; you should curate the most relevant set):
```bibtex
@article{Aydelotte2017,
  author = {Aydelotte, Justin D. and Brown, Louis H. and Luftman, Kathleen M. and Mardock, Anna L. and Teixeira, Paula G. R. and Coopwood, T. Bradley and Brown, Christopher V. R.},
  title = {Crash Fatality Rates After Recreational Marijuana Legalization in Washington and Colorado},
  journal = {American Journal of Public Health},
  year = {2017},
  volume = {107},
  number = {8},
  pages = {1329--1331}
}

@article{SantaellaTenorio2017,
  author = {Santaella-Tenorio, Julian and Mauro, Christine M. and Wall, Melanie M. and Kim, June H. and Cerda, Magdalena and Keyes, Katherine M. and Hasin, Deborah S. and Martins, Silvia S.},
  title = {US Traffic Fatalities, 1985--2014, and Their Relationship to Medical Marijuana Laws},
  journal = {American Journal of Public Health},
  year = {2017},
  volume = {107},
  number = {2},
  pages = {336--342}
}
```
(If you want economics-first citations, you should also add more recent econ work on recreational legalization and traffic outcomes and carefully discuss why your measurement of THC differs from “alcohol-involved” classifications.)

## Why these matter for *this* paper
- You lean heavily on **RDD/DiD motivation** (Sections 6 and 8, pp.17–23). Without the canonical RDD references (Lee & Lemieux; Calonico et al.; McCrary), the paper reads methodologically undercited.
- Because your outcome is **geocoded and spatially correlated**, Conley-style inference (or modern spatial randomization inference) is central.
- Because your key dependent variable is a **selected “drug finding present” denominator** (pp.3–4; p.20–21), you must engage with measurement and selection literature in the drugged driving space.

---

# 5. WRITING QUALITY (critical evaluation)

### (a) Prose vs bullets
- Mostly acceptable: core narrative sections are prose.
- However, many sections read like **documentation plus figure captions** rather than an economics argument. For a top journal, even a “data paper” needs a sharper narrative about *what new economic questions become answerable* and *why prior work could not answer them*.

### (b) Narrative flow
- The Introduction (pp.1–3) is competent and clear.
- The paper’s arc is weakened because it simultaneously says:
  1) “This is descriptive, not causal” (p.2), but
  2) repeatedly foregrounds “sharp border discontinuities” and “spatial RDD designs” (Abstract p.1; Sections 4, 6, 8).
  
  A top-journal reader will expect at least one fully executed design, not just motivation.

### (c) Sentence quality
- Generally readable, but there is repetition (multiple reminders that FARS reports findings not panels; multiple reminders THC ≠ impairment).
- Some claims are stated with precision (“~20% vs ~10%”) without uncertainty or inference, which makes the prose sound more definitive than the underlying data support.

### (d) Accessibility
- Good explanations of FARS and OSM. The limitations of THC detection are clearly explained (pp.21–22; p.23–24).
- What is missing is an intuitive econometric discussion of **why border RDD is credible here given cross-border travel and enforcement**, and what the relevant estimand is (e.g., intent-to-treat exposure vs actual consumption).

### (e) Figures/Tables quality
- Many figures are reasonably labeled, but several map figures would need:
  - clearer scale bars consistently,
  - consistent color palettes across figures (THC vs policy status vs substance categories vary),
  - better text size for print reproduction.

---

# 6. CONSTRUCTIVE SUGGESTIONS (how to make it publishable/impactful)

## A. Decide what paper this is
Right now it sits awkwardly between a **data descriptor** and a **causal policy evaluation**. For AEJ:EP/top general-interest, you likely need **at least one credible causal design executed end-to-end**.

Two viable paths:

### Path 1: Turn it into a real causal border-RDD paper (recommended if you want top-5/AEJ:EP)
Deliver a full spatial RDD analysis for a small set of high-sample borders (CO–WY, WA–ID, OR–ID, NV–UT):
1. **Define the estimand** clearly: effect of recreational legality (or retail opening) on:
   - probability crash has THC finding **conditional on having a drug record** (selected sample), and separately
   - probability crash has *any* drug record (testing/reporting margin),
   - alcohol involvement (drunk_dr),
   - crash counts per exposure (needs denominator: VMT or population).
2. Implement canonical RDD:
   - local linear with bias correction (Calonico et al.),
   - multiple bandwidths + data-driven bandwidth selection,
   - donut RDD excluding crashes extremely close to the border (to address geocoding error and border sorting),
   - **McCrary density test** (or adapted density test on distance-to-border for crash locations) and discussion of what “manipulation” means here,
   - covariate continuity: road class, speed limit availability, nighttime share, weather, etc.
3. Inference:
   - spatial correlation-robust SEs (Conley) or cluster by border segment/grid cell,
   - randomization inference using permutation of “legal side” labels along the border as a robustness exercise.
4. Address cross-border travel explicitly:
   - restrict to crashes involving in-state drivers (if available),
   - or use distance to nearest dispensary / retail opening as an exposure gradient.

### Path 2: Make it an explicit “data and measurement” paper
If you insist it is non-causal, you must still add **formal statistical measurement content**:
- quantify uncertainty around all reported differences (bootstrap CIs at minimum),
- systematically analyze missingness and selection into drug records:
  - model/report predictors of having a drug record,
  - present bounding exercises (e.g., worst/best-case bounds on THC prevalence under plausible testing differentials),
  - compare with states known to have higher testing coverage if such metadata exist.
- validate OSM snapping quality:
  - show snap distance distributions by urban/rural/state,
  - demonstrate robustness of road-type assignments.

## B. Fill the missing years or narrow claims
Your omission of 2006–2015 is fatal for any serious policy evaluation because it removes:
- pre-trends for early legalizers (CO/WA 2012),
- adoption dynamics,
- event-study credibility.

Either:
- extend the pipeline to 2006–2015 (strongly preferred), or
- **narrow the paper** to a pure cross-sectional 2018–2019 border design and stop gesturing to DiD.

## C. Improve outcome construction
- Your THC indicator is “THC mentioned among reported drug findings,” not “THC positive among tested.” This is central and currently makes the key statistic (20% vs 10%) hard to interpret causally (pp.3–4; p.20–21).
- A publishable paper needs:
  - alternative THC measures (drug codes pre-2018 as “cannabinoid”), harmonized carefully,
  - explicit separation of (i) testing/reporting propensity, (ii) positivity conditional on testing/reporting.

## D. Add denominators and exposure measures
Crashes are counts; without exposure denominators you cannot interpret safety effects.
- Add VMT (FHWA), population, or traffic counts at least at county/year.
- For spatial RDD, consider using **road-segment traffic volumes** where possible (even coarse proxies) or at minimum road class × urbanicity controls.

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Valuable integration of FARS geocodes with OSM and policy timing (Section 2, pp.3–6).
- Clear, candid discussion of limitations (Sections 7 and 9, pp.19–24).
- The maps demonstrate potentially interesting spatial structure and could underpin serious empirical work.

### Critical weaknesses (deal-breakers)
1. **No statistical inference** (no SEs, no CIs, no tests). This alone fails top-journal standards.
2. **No implemented identification strategy** despite repeated motivation of RDD/DiD.
3. **RDD and DiD are invoked but not executed**, and canonical diagnostics (bandwidth sensitivity, McCrary, covariate continuity) are absent.
4. **Literature engagement is far too thin**, especially for methods and for cannabis/traffic safety measurement.
5. The paper currently reads as a **repository description** rather than a polished economics article with an estimand, identification, and inference.

### What would change my view
If the authors (i) implement a full border RDD with proper inference and diagnostics for one or two borders and (ii) explicitly model/bound the drug-reporting selection problem, the paper could become a credible AEJ:EP-style contribution. As written, it is not yet in the set of papers a top general-interest journal could send forward.

---

DECISION: REJECT AND RESUBMIT